BUSINESS

• Thorsten Poehl Takes Helm of Boehringer Japan
  May 10, 2016

• D. Western Therapeutics Acquires Exclusive License to Corneal Endothelial Therapeutics from Doshisha Univ.
  May 10, 2016

• Transfer of Vaccine, Blood Biz under Negotiation, All Directors to Exit in June: Kaketsuken
  May 9, 2016

• Ex-Ranbaxy Shareholders Ordered to Pay 56 Billion Yen to Daiichi Sankyo
  May 9, 2016

• Shingo Iwamoto to Lead Aspen Japan
  May 9, 2016

• Halaven Approved for Advanced Liposarcoma in Europe: Eisai
  May 9, 2016

• Brintellix Renamed Trintellix to Curb Name Confusion in US
  May 9, 2016

• Ono Ups FY2015 Earnings Forecast on Brisk Opdivo Sales
  May 9, 2016

• Sales Rep Survey - Part 2: Drug Makers Exploring Viable Roles amid Govt’s Community-Based Care Initiative
  May 6, 2016

• Sales Rep Survey - Part 1: Number of Reps at Foreign Drug Makers Declines Sharply; Down by 330 at GSK
  May 2, 2016

• 53 Drug Makers Hire 200 Less New Grads in FY2016, Japan Firms See Hefty Drop: Jiho Tally
  April 28, 2016

• Kenji Sukeno to Become New Fujifilm Holdings President
  April 28, 2016

• Nogimori to Bow Out as Astellas Chairman
  April 28, 2016

• Kaken Licenses Severe Burn Treatment from Israeli Firm
  April 27, 2016

• Biogen Eyes Simultaneous Filings in Japan, US, Europe for Alzheimer’s Drug Aducanumab
  April 27, 2016

• Harvoni Most Prescribed Drug at Acute Hospitals in October-December
  April 27, 2016

• Chugai, Hiroshima Univ. Spinoff Join Hands in Cartilage Regeneration
  April 26, 2016

• Boehringer Japan’s Ethical Drug Sales Tick Up 2% in 2015
  April 26, 2016

• Novartis Seeks Add’l Indications for Ilaris in Japan
  April 26, 2016

• Novartis Looks to Harness Big Data for Indication Expansions: Global Medical Chief
  April 26, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 493
• 494
• 495
• 496
• 497
• 498
• 499
• 500
• 501
• …
• Next ›
• 最終 »